| LBPEA01 | Broad HIV-1 inhibition elicited by human data-driven HIVconsvX conserved T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 005.2: an open-label, non-randomized, dose-escalation, first-in-man phase 1 trial | Poster exhibition | Novel treatment and prevention strategies |
| OAA0203 | In vivo genome engineering of human T cells results in ART-free control of HIV-1 in humanized mice | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OAA0204 | The EZH2 inhibitor Tazemetostat increases MHC-I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OAA0205 | Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers of rhesus macaques | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OALBA0504 | Absence of viral rebound for 18 months without antiretrovirals after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells to treat a biphenotypic sarcoma | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| TUPEA11 | DPP9 inhibitors: a novel class of drugs for clearance of HIV-1 infected cells | Poster exhibition | Novel treatment and prevention strategies |
| EPC0348 | Adherence is the key: targeting long-acting injectable cabotegravir to MSM current oral PrEP users with low adherence would be highly effective and efficient, a modelling study with Dutch perspectives | E-poster | Modelling the HIV epidemic |
| EPC0349 | Modeled estimates of HIV-serodifferent couples in tuberculosis-affected households in sub-Saharan Africa | E-poster | Modelling the HIV epidemic |
| EPC0350 | Projecting future health system usage under HIV and TB program scale-up in Malawi | E-poster | Modelling the HIV epidemic |
| EPC0351 | Projected impact of scaling up a crowdsourced intervention to improve HIV self-testing among youth living in Nigeria | E-poster | Modelling the HIV epidemic |